Literature DB >> 33312367

Effects of miR-22-3p targeted regulation of Socs3 on the hepatic insulin resistance in mice with gestational diabetes mellitus.

Huan Zhang1, Qiaoyi Wang2, Kun Yang3, Hanjing Zheng1, Yujing Hu4.   

Abstract

OBJECTIVE: Gestational diabetes mellitus (GDM) is one of the common complications of pregnant women, with serious threatening to pregnant women and newborns. The pathogenesis of GDM remains unclear now. This study aims to explore the effects of miR-22-3p targeted regulation of suppressors of cytokine signaling 3 (Socs3) on the hepatic insulin resistance (HIR) in mice with GDM.
METHODS: Healthy SPF C57BL/6J mice were selected to establish GDM model and divided into 7 groups: Normal group, Model group, NC-(negative control) mimic group, miR-22-3p mimic group, NC-pcDNA3.0 group, pcDNA3.0-Socs3 group, and miR-22-3p mimic + pcDNA3.0-Socs3 group. The islet morphology, and the expressions of miR-22-3p, Socs3 mRNA and Socs3 protein in the islet tissues were detected by HE staining, qRT-PCR and Western blot. Fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C) were measured. Oral glucose tolerance test (OGTT) was performed to detect FBG and fasting insulin (FINS) contents, and insulin resistance (HOMA-IR) was calculated.
RESULTS: Compared with the Normal group, the model group had decreased levels of miR-22-3p and HDL-C, while increased levels of Socs3 mRNA and protein expressions, OGTT, FBG, FINS, and HOMA-IR, TG and TC (all P < 0.05). Compared with the Model group, the above indicators (OGTT, FBG, FINS, HOMA-IR, TG, TC and HDL-C) were improved in the miR-22-3p mimic group, but worsened in the pcDNA3.0-Socs3 group (all P < 0.05).
CONCLUSION: miR-22-3p can down-regulate the expression of Socs3, thereby inhibiting HIR in GDM mice. AJTR
Copyright © 2020.

Entities:  

Keywords:  effect; gestational diabetes mellitus; hepatic insulin resistance; miR-22-3p; suppressors of cytokine signaling 3

Year:  2020        PMID: 33312367      PMCID: PMC7724336     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  3 in total

1.  Optimization of miR-22 expression cassette for rAAV delivery on diabetes.

Authors:  Li Yang; Wenya Du; Zhaoyue Zheng; Li Wang; Lin Xiao; Qingzhe Yang; Qiukui Hao; Jiao Zhou; Jintao Du; Jun Li; C Alexander Valencia; Birong Dong; Hoi Yee Chow; Xianghui Fu; Biao Dong
Journal:  Mol Biomed       Date:  2022-01-05

2.  High Glucose Reduces the Paracellular Permeability of the Submandibular Gland Epithelium via the MiR-22-3p/Sp1/Claudin Pathway.

Authors:  Yan Huang; Hui-Min Liu; Qian-Ying Mao; Xin Cong; Yan Zhang; Sang-Woo Lee; Kyungpyo Park; Li-Ling Wu; Ruo-Lan Xiang; Guang-Yan Yu
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

3.  The downregulation of miR-22 and miR-372 may contribute to gestational diabetes mellitus through regulating glucose metabolism via the PI3K/AKT/GLUT4 pathway.

Authors:  Wei Li; Xianlin Yuan; Xin He; Li Yang; Yingyuan Wu; Xiaofeng Deng; Yiwen Zeng; Kesheng Hu; Bo Tang
Journal:  J Clin Lab Anal       Date:  2022-06-17       Impact factor: 3.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.